Literature DB >> 20299182

Thrombospondin-1: a proatherosclerotic protein augmented by hyperglycemia.

Kristopher G Maier1, Xuan Han, Benjamin Sadowitz, Karen L Gentile, Frank A Middleton, Vivian Gahtan.   

Abstract

OBJECTIVE: Diabetes is associated with a more aggressive form of atherosclerosis. Thrombospondin-1 (TSP-1), an extracellular matrix protein, is an acute-phase reactant that induces vascular smooth muscle (VSMC) migration and proliferation in areas of vascular injury and is also up-regulated in VSMCs exposed to hyperglycemia. This study tested the hypothesis that hyperglycemia amplifies the expression of genes induced by TSP-1 in VSMCs.
METHODS: Human aortic VSMCs were cultured in Dulbecco Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics. Cells were used between passages three and five. VSMCs were preincubated in DMEM containing 0.2% FBS with 5 mM glucose (normoglycemia), 25 mM glucose (hyperglycemia), 25 mM mannose (osmotic control), TSP-1 (20 microg/mL), 25 mM glucose + TSP-1 (20 microg/mL), or 25 mM mannose + TSP-1 (20 microg/mL). Total RNA was extracted. Microarray analysis was performed and analyzed by analysis of variance. P < .05 was considered significant. Quantitative real-time polymerase chain reaction (rtPCR) was used to confirm selected up-regulated genes.
RESULTS: Microarray analysis revealed: (1) hyperglycemia altered 30 genes; (2) TSP-1 altered 212 genes, of which 8 were altered similarly to VSMCs exposed to 25 mM glucose; (3) TSP-1 up-regulated 10 genes associated with atherosclerosis and 4 others with diabetic vascular disease; (4) hyperglycemia combined with TSP-1 altered expression of 2822 genes. The three genes most up-regulated by TSP-1 in a normoglycemic environment were uridine 5'-diphosphoglucose (UDP-glucose) dehydrogenase (UGDH, 127%), transforming growth factor beta-2 (TGFbeta2, 116%), and hyaluronan synthase 2 (HAS2, 113%). Further, TSP-1 altered the expression of genes in 13 canonical pathways; however, when combined with hyperglycemia, 53 canonical pathways were affected.
CONCLUSION: Quantitative rtPCR confirmed that genes in several of these pathways for TSP-1 and hyperglycemia combined with TSP-1 were up-regulated. These findings suggest that TSP-1 may be germane to the progression of atherosclerosis and may have a large effect with concurrent hyperglycemia. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299182     DOI: 10.1016/j.jvs.2009.11.073

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  15 in total

1.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

2.  Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm.

Authors:  Zhenjie Liu; Stephanie Morgan; Jun Ren; Qiwei Wang; Douglas S Annis; Deane F Mosher; Jing Zhang; Christine M Sorenson; Nader Sheibani; Bo Liu
Journal:  Circ Res       Date:  2015-05-04       Impact factor: 17.367

3.  Thrombospondin-1 differentially regulates microRNAs in vascular smooth muscle cells.

Authors:  Kristopher G Maier; Brian Ruhle; Jeffrey J Stein; Karen L Gentile; Frank A Middleton; Vivian Gahtan
Journal:  Mol Cell Biochem       Date:  2016-01-04       Impact factor: 3.396

Review 4.  Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.

Authors:  Joanne E Murphy-Ullrich; Mark J Suto
Journal:  Matrix Biol       Date:  2017-12-27       Impact factor: 11.583

5.  Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1.

Authors:  Tiina A Jokela; Katri M Makkonen; Sanna Oikari; Riikka Kärnä; Elina Koli; Gerald W Hart; Raija H Tammi; Carsten Carlberg; Markku I Tammi
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

6.  Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.

Authors:  Alex Helkin; Kristopher G Maier; Vivian Gahtan
Journal:  Biochem Biophys Res Commun       Date:  2015-07-11       Impact factor: 3.575

7.  Glucose and insulin modify thrombospondin 1 expression and secretion in primary adipocytes from diet-induced obese rats.

Authors:  Diego F Garcia-Diaz; Arianna V Arellano; Fermin I Milagro; Maria Jesus Moreno-Aliaga; Maria Puy Portillo; J Alfredo Martinez; Javier Campion
Journal:  J Physiol Biochem       Date:  2011-03-11       Impact factor: 4.158

8.  Association of Plasma Thrombospondin-1 Level with Cardiovascular Disease and Mortality in Hemodialysis Patients.

Authors:  Chi-Lun Huang; Yuh-Shiun Jong; Yen-Wen Wu; Wei-Jie Wang; Ai-Ru Hsieh; Chia-Lun Chao; Wen-Jone Chen; Wei-Shiung Yang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

9.  Thrombospondin 1 mediates renal dysfunction in a mouse model of high-fat diet-induced obesity.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Xinyu Qi; Heather Norman; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

10.  Thrombospondin-1-induced smooth muscle cell chemotaxis and proliferation are dependent on transforming growth factor-β2 and hyaluronic acid synthase.

Authors:  Jeffrey J Stein; Chinenye Iwuchukwu; Kristopher G Maier; Vivian Gahtan
Journal:  Mol Cell Biochem       Date:  2013-10-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.